• Privacy policy
  • T&C’s
  • About Us
    • FAQ
    • Meet the Team
  • Contact us
  • Guest Content
TLE ONLINE SHOP!
  • TLE
  • News
  • Politics
  • Opinion
    • Elevenses
  • Business
  • Food
  • Travel
  • Property
  • JOBS
  • All
    • All Entertainment
    • Film
    • Sport
    • Tech/Auto
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
No Result
View All Result
The London Economic
SUPPORT THE LONDON ECONOMIC
NEWSLETTER
  • TLE
  • News
  • Politics
  • Opinion
    • Elevenses
  • Business
  • Food
  • Travel
  • Property
  • JOBS
  • All
    • All Entertainment
    • Film
    • Sport
    • Tech/Auto
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
No Result
View All Result
The London Economic
No Result
View All Result
Home Lifestyle Health

Alzheimer’s disease reversed in mice with drug that targets the brain’s immune cells

The breakthrough could lead to a cure for the devastating neurological illness, say scientists

Steve Beech by Steve Beech
2019-10-10 14:05
in Health, Lifestyle
Photo: PA

Photo: PA

FacebookTwitterLinkedinEmailWhatsapp

Alzheimer’s disease has been reversed in mice with a drug that targets the brain’s immune cells.

The breakthrough could lead to a cure for the devastating neurological illness, say scientists.

Experiments found blocking the production of cells known as microglia kept grey matter healthy.

Found in the brain and spinal cord, they control the immune system of the central nervous system.

It adds to a growing body of evidence that dementia is driven by inflammation – caused by a build up of microglia.

Previous studies have found high levels of the cells in the post-mortem brains of people with Alzheimer’s.

They are “the linchpin of the neurodegenerative process,” according to the US team. Up until now the focus has been on a rogue protein called tau.

In Alzheimer’s it forms into tangles, destroying neurons. But the process is fuelled by microglia, said senior author Professor David Holtzman,

The findings could lead to new treatments for dementia and other tau linked illnesses such as chronic traumatic encephalopathy (CTE) and Parkinson’s disease.

RelatedPosts

Lucky Numbers and Horoscopes for today 4 June 2023

Lucky Numbers and Horoscopes for today 3 June 2023

Keeping Your Business Spotless: The Benefits of Commercial Carpet Cleaning in London

Lucky Numbers and Horoscopes for today 2 June 2023

The compound used on the lab rodents has side effects – making it unsuitable for humans. But it opens the door to others that singles out microglia.

Prof Holtzman, a neurologist at Washington University, St Louis, said: “If you could target microglia in some specific way and prevent them from causing damage, I think that would be a really important, strategic, novel way to develop a treatment.”

The study, published in the Journal of Experimental Medicine, found the cells are triggered as tau accumulates – forming the crucial link between protein clumping and brain damage.

Eliminating them dramatically reduced tau in the mice – protecting them against brain damage.

Suppressing microglia, may prevent or delay the onset of dementia in people, said Prof Holtzman.

The disease affects 850,000 people in the UK – with the number set to rise to 2 million by 2050. A drug that treats the cause is the ‘holy grail’ of research.

Prof Holtzman said: “Right now many people are trying to develop new therapies for Alzheimer’s disease, because the ones we have are simply not effective.

“If we could find a drug that specifically deactivates the microglia just at the beginning of the neurodegeneration phase of the disease, it would absolutely be worth evaluating in people.”

Under ordinary circumstances, tau contributes to the normal, healthy functioning of brain neuron.

In some people, though, it collects into toxic tangles that are a hallmark of Alzheimer’s and CTE, a progressive brain disease often diagnosed in boxers who have sustained repeated blows to the head.

So Prof Holtzman and lab member Dr Yang Shi analysed genetically modified mice with a mutant form of human tau that easily clumps together.

Typically, they start developing tangles at six months of age – and show signs of neurological damage by nine months.

Animals engineered to carry a variant known as APOE4 – which raises people’s risk of Alzheimer’s twelve-fold – were protected after by a drug that depleted microglia in their brains.

After being fed it for three months their brains looked essentially normal and healthy, with less evidence of harmful tau despite the presence of the mutation.

The brains of those given a placebo were severely shrunken and damaged by nine and a half months age – as long as microglia were also present.

Prof Holtzman said: “Tangles of tau form inside neurons as Alzheimer’s develops, attracting the microglia.

“The protein APOE collects inside the microglia, activating them. This causes brain damage, leading to forgetfulness and confusion.”

What is more, mice with microglia and the mutant human tau but no APOE also had minimal brain damage – and fewer signs of the dangerous tangles.

Microglia need APOE to destroy brain tissue and boost the production of tau, the researchers said.

Co author Dr Shi added: “Microglia drive neurodegeneration, probably through inflammation-induced neuronal death.

“But even if that’s the case, if you don’t have microglia, or you have microglia but they can’t be activated, harmful forms of tau do not progress to an advanced stage, and you don’t get neurological damage.”

There has not been a new dementia drug for 15 years. With an ageing population, the need to find treatments that can slow or stop disease progression is greater than ever, say Alzheimer’s charities.

Call for compulsory annual memory tests for over 65s to spot dementia signs

Content Protection by DMCA.com

Subscribe to our Newsletter

View our  Privacy Policy and Terms & Conditions

Trending on TLE

  • All
  • trending

Elevenses: The Thing About Wrexham’s Cinderella Story

Elevenses: Exposing the Tories’ Deepfake Illegal Immigration Bill

Elevenses: Rishi’s Finest Hour

More from TLE

Pull the other one: Would you get the ‘puppet’ facelift?

Lucky Numbers and Horoscopes for today, 19 September 2021

Iconic animals threatened by surge in humans in Masai Mara & Serengeti national parks

Euro final will ‘absolutely’ go ahead with over 60,000 fans as German minister condemns ‘irresponsible’ Uefa

A workers’ party could not have backed a Tory Brexit in good conscience

Johnson’s Brexit proposals would leave the UK economy worse off than May’s deal

Prince Andrew ‘increasingly confident’ of royal comeback after Philip’s funeral

Women want DIY…men demand better sex

PR v Marketing at the 2014 World Cup

VIDEO – Gay cyclist closes down ‘anti-LGBT preacher’ & gets applause

About Us

TheLondonEconomic.com – Open, accessible and accountable news, sport, culture and lifestyle.

Read more

Contact

Editorial enquiries, please contact: [email protected]

Commercial enquiries, please contact: [email protected]

Address

The London Economic Newspaper Limited t/a TLE
Company number 09221879
International House,
24 Holborn Viaduct,
London EC1A 2BN,
United Kingdom

SUPPORT

We do not charge or put articles behind a paywall. If you can, please show your appreciation for our free content by donating whatever you think is fair to help keep TLE growing and support real, independent, investigative journalism.

DONATE & SUPPORT

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.




No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • JOBS
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Meet the Team
    • Privacy policy
  • Contact us

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.